Opioid | Addiction Treatment Strategies

Johnson & Johnson has attained approval for their long standing opioid Nucynta in extended release format by the U.S. Food and Drug Administration. Nucynta has a high potential for abuse, and users may become psychologically or physically dependent on the drug so this approval is…

If you want to know how people become addicted and why they keep using drugs, ask the people who are addicted.
 Thirty-one of 75 patients hospitalized for opioid detoxification told University at Buffalo physicians they first got hooked on drugs legitimately prescribed for pain.
Another 24…

Buprenorphine is a synthetic opioid that is used for pain management and was approved in 2002 to treat opioid dependence.
What are the forms of buprenorphine? Although there are several forms of buprenorphine (including Buprenex®, an injectable liquid used for pain treatment), only Subutex®…

LifeSource , a nonprofit organization established to fund healthcare-related projects, is addressing the nation’s biggest healthcare problem. According to the Food and Drug Administration (FDA), 29 million Americans age 12 and older misused extended-release and long-acting opioids in…

Deaths related to prescription opioid therapy are under intense scrutiny, prompting those in pain medicine — clinicians, patient advocates, and regulators — to understand the causes behind avoidable mortality in legitimately treated patients. Studies reporting on statistics,…

Research links frequent prescribing to opioid-related deaths
TORONTO, Ont., March 14, 2011 — Some physicians are prescribing opioids such as OxyContin 55 times as often as others, according to a new study led by St. Michael’s Hospital and the Institute for Clinical Evaluative…